{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:20:50Z","timestamp":1783099250780,"version":"3.54.6"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011408","name":"State Key Laboratory of Medicinal Chemical Biology","doi-asserted-by":"publisher","award":["SKLCB-2025-01"],"award-info":[{"award-number":["SKLCB-2025-01"]}],"id":[{"id":"10.13039\/501100011408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204187"],"award-info":[{"award-number":["82204187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373720"],"award-info":[{"award-number":["82373720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bmcl.2026.130685","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:02:51Z","timestamp":1778889771000},"page":"130685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-carboxamides as apelin receptor agonists"],"prefix":"10.1016","volume":"138","author":[{"given":"Chong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2026.130685_bb0005","doi-asserted-by":"crossref","unstructured":"Medhurst, A. D.; Jennings, C. A.; Robbins, M. J.; Davis, R. P.; Ellis, C.; Winborn, K. Y.; Lawrie, K. W. M.; Hervieu, G.; Riley, G.; Bolaky, J. E.; et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003, 84 (5), 1162\u20131172. DOI: doi:https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01587.x (acccessed 2024\/11\/29).","DOI":"10.1046\/j.1471-4159.2003.01587.x"},{"key":"10.1016\/j.bmcl.2026.130685_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170697","article-title":"Apelin pathway in cardiovascular, kidney, and metabolic diseases: therapeutic role of apelin analogs and apelin receptor agonists","volume":"147","author":"de Oliveira","year":"2022","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130685_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12551-023-01044-x","article-title":"Structure\u2013function relationship and physiological role of apelin and its G protein coupled receptor","volume":"15","author":"Murali","year":"2023","journal-title":"Biophys Rev"},{"issue":"7411","key":"10.1016\/j.bmcl.2026.130685_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature11263","article-title":"APJ acts as a dual receptor in cardiac hypertrophy","volume":"488","author":"Scimia","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2026.130685_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2016.07.018","article-title":"Cardiac action of the first G protein biased small molecule apelin agonist","volume":"116","author":"Read","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130685_bb0030","series-title":"Preparation of Benzimidazolecarboxylic Acid Amino Acid Amides as Apelin Receptor Modulators","author":"Hachtel","year":"2014"},{"issue":"7","key":"10.1016\/j.bmcl.2026.130685_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.126955","article-title":"Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ","volume":"30","author":"Myers","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130685_bb0040","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1021\/acs.jmedchem.0c01878","article-title":"Discovery of a hydroxypyridinone APJ receptor agonist as a clinical candidate","volume":"64","author":"Johnson","year":"2021","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130685_bb0045","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1021\/acsmedchemlett.1c00385","article-title":"Identification of 6-hydroxypyrimidin-4(1H)-one-3-carboxamides as potent and orally active APJ receptor agonists","volume":"12","author":"Pi","year":"2021","journal-title":"ACS Med Chem Lett"},{"issue":"24","key":"10.1016\/j.bmcl.2026.130685_bb0050","doi-asserted-by":"crossref","first-page":"18102","DOI":"10.1021\/acs.jmedchem.1c01504","article-title":"Identification of a hydroxypyrimidinone compound (21) as a potent APJ receptor agonist for the potential treatment of heart failure","volume":"64","author":"Meng","year":"2021","journal-title":"J Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130685_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115237","article-title":"Identification of potent pyrazole based APELIN receptor (APJ) agonists","volume":"28","author":"Narayanan","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130685_bb0060","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1021\/acs.jmedchem.0c01448","article-title":"Pyrazole agonist of the apelin receptor improves symptoms of metabolic syndrome in mice","volume":"64","author":"Narayanan","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130685_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116789","article-title":"Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor","volume":"66","author":"Narayanan","year":"2022","journal-title":"Bioorg Med Chem"},{"issue":"21","key":"10.1016\/j.bmcl.2026.130685_bb0070","doi-asserted-by":"crossref","first-page":"22312","DOI":"10.1021\/acs.jmedchem.5c01176","article-title":"Development of central nervous system-penetrant apelin receptor agonists","volume":"68","author":"Narayanan","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130685_bb0075","series-title":"Preparation of Novel Azole Derivatives as Apelin Receptor Agonists","author":"Ikeda","year":"2017"},{"key":"10.1016\/j.bmcl.2026.130685_bb0080","series-title":"Triazoles as Agonists of the APJ Receptor and their Preparation","author":"Chen","year":"2016"},{"key":"10.1016\/j.bmcl.2026.130685_bb0085","series-title":"Compounds and Compositions for Treating Conditions Associated with APJ Receptor Activity","author":"Tang","year":"2019"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130685_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55381-w","article-title":"Structural and functional determination of peptide versus small molecule ligand binding at the apelin receptor","volume":"15","author":"Williams","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2026.130685_bb0095","article-title":"Structure-based design of non-hypertrophic apelin receptor modulator","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130685_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-62870-z","article-title":"Mechanistic insights into the versatile stoichiometry and biased signaling of the apelin receptor-arrestin complex","volume":"16","author":"Yue","year":"2025","journal-title":"Nat Commun"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:41:35Z","timestamp":1783096895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"alternative-id":["S0960894X26001526"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130685","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-carboxamides as apelin receptor agonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130685"}}